Doctor of Podiatric Medicine Program year 2024 Reported 2019–2024 Source: CMS Open Payments, 2026 publication

Hilary Nosker

Podiatrist Winchester, VA Doctor of Podiatric Medicine

NPI 1326336256 CMS profile 242268

117 N Braddock St, Suite 150, Winchester, VA 22601

Open in the dashboard

General payments

$2,215

75 records reported · program years 2019–2024

Research payments

$0

Paid to them · None reported · program years 2019–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Hilary Nosker of Winchester, VA is reported in the CMS Open Payments database as having received $2,215 across 75 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 68th percentile of Podiatrist profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $234 6
2023 General $248 11
2022 General $439 15
2021 General $322 13
2020 General $304 16
2019 General $669 14

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Hilary Nosker
  • Podiatrist median
  • Middle half of Podiatrist
  • National median

In program year 2025, general payments to Hilary Nosker were reported at $0. Among 4,572 Podiatrist profiles paid that year, the median was $260 and the middle half received between $94 and $777.

Show as a table
Year Hilary Nosker Podiatrist median Middle half National median
2019 $669 $196 $72–$601 $163
2020 $304 $118 $38–$335 $114
2021 $322 $169 $57–$573 $132
2022 $439 $220 $74–$782 $149
2023 $248 $208 $71–$635 $160
2024 $234 $237 $87–$681 $164
2025 $0 $260 $94–$777 $169

Breakdown

Who paid General payments · program years 2019–2024
  1. Smith+Nephew, Inc. $1,851 70 payments
  2. Osiris Therapeutics Inc. $148 2 payments
  3. Abbott Laboratories $108 1 payment
  4. Integra LifeSciences Corporation $92 1 payment
  5. Hartmann USA, Inc. $16 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2024
  1. Food and Beverage $2,215 75 payments
Products named General payments · program years 2019–2024
  1. GRAFIX PL Other Advanced Wound Management $629 24 payments
  2. Stravix Other Advanced Wound Management $502 13 payments
  3. GRAFIX Other Advanced Wound Management $412 12 payments
  4. GRAFIX Other Advanced Wound Management $296 8 payments
  5. GRAFIX PL Other Advanced Wound Management $264 14 payments
  6. STRAVIX Extremities & Limb Restoration $260 8 payments
  7. GrafixPL $248 6 payments
  8. Oasis Extra Cellular Matrix $181 8 payments
  9. OASIS Extra Cellular Matrix $114 5 payments
  10. Axium INS DRG IPG $108 1 payment
  11. Other $826 25 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 1 drug

Part D claims

12

Median for Podiatry: 160

Drug cost

$339

Median for Podiatry: $2,368

Branded share of claims

0%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Ketoconazole Generic 12 $339

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 34 billing codes

Paid by Medicare

$108,731

Of which drugs: $12

Medicare patients

385

Average age 79

Services billed

2,438

217 women, 168 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 56%
Chronic kidney disease 44%
Diabetes 42%
Ischemic heart disease 33%
Atrial fibrillation 25%
Heart failure 23%
Depression 21%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 11 16 $12

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

75 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist in Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record